rs587784169
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000439151.7(NSD1):c.5951G>A(p.Arg1984Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1984P) has been classified as Pathogenic.
Frequency
Consequence
ENST00000439151.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NSD1 | NM_022455.5 | c.5951G>A | p.Arg1984Gln | missense_variant | 19/23 | ENST00000439151.7 | NP_071900.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NSD1 | ENST00000439151.7 | c.5951G>A | p.Arg1984Gln | missense_variant | 19/23 | 1 | NM_022455.5 | ENSP00000395929 | P2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Sotos syndrome Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 30, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1984 of the NSD1 protein (p.Arg1984Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Sotos syndrome (PMID: 12807965, 15942875, 16247291, 17561922, 17565729). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 159390). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NSD1 protein function. Experimental studies have shown that this missense change affects NSD1 function (PMID: 21196496, 24412544, 27834868). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 19, 2024 | Variant summary: NSD1 c.5951G>A (p.Arg1984Gln) results in a conservative amino acid change located in the SET domain (IPR001214) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251304 control chromosomes (gnomAD). c.5951G>A has been reported in the literature in individuals affected with Sotos Syndrome, including one de novo occurrence (Tatton-Brown_2005, Lu_2017). These data indicate that the variant is likely to be associated with disease. At least two publication report experimental evidence evaluating an impact on protein function and this variant results in completely lost its ability to methylate H3 (Qiao_2010, Kudithipudi_2014). The following publications have been ascertained in the context of this evaluation (PMID: 27834868, 24412544, 29142766, 21196496, 15942875). ClinVar contains an entry for this variant (Variation ID: 159390). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 13, 2021 | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21196496, 17565729, 24412544, 27834868, 16010675, 17561922, 15452385, 16247291, 12807965, 29142766) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at